Evidence map›Paper›PMID 35163824›Full record

ArticleInternational journal of molecular sciences2022

Identification of Corosolic and Oleanolic Acids as Molecules Antagonizing the Human RORγT Nuclear Receptor Using the Calculated Fingerprints of the Molecular Similarity.

Joanna Pastwińska, Kaja Karaś, Anna Sałkowska, Iwona Karwaciak, Katarzyna Chałaśkiewicz, Błażej A Wojtczak, Rafał A Bachorz, Marcin Ratajewski

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Review
  2. Synergistic Effect ofBiology · 2024
    Article
  3. Review
  4. Review
  5. In Vitro and In Vivo Anti-Psoriasis Activity ofLife (Basel, Switzerland) · 2023
    Article
  6. Corosolic Acid Inhibits Secretory Phospholipase AJournal of inflammation research · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Joanna PastwińskaLaboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.
Kaja KaraśLaboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.ORCID 0000-0002-1790-698X
Anna SałkowskaLaboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.
Iwona KarwaciakLaboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.
Katarzyna ChałaśkiewiczLaboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.
Błażej A WojtczakCentre of New Technologies, University of Warsaw, 02-097 Warsaw, Poland.ORCID 0000-0002-7448-7216
Rafał A BachorzLaboratory of Molecular Modeling, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.
Marcin RatajewskiLaboratory of Epigenetics, Institute of Medical Biology, Polish Academy of Sciences, 93-232 Lodz, Poland.ORCID 0000-0001-5391-5843
Polish Academy of Sciences · PLInstitute for Medical Biology · PLUniversity of Warsaw · PL

Funding

National Science Center 2019/33/B/NZ7/00795
6 · The paper itself

Abstract

RORγT is a protein product of the RORC gene belonging to the nuclear receptor subfamily of retinoic-acid-receptor-related orphan receptors (RORs). RORγT is preferentially expressed in Th17 lymphocytes and drives their differentiation from naive CD4+ cells and is involved in the regulation of the expression of numerous Th17-specific cytokines, such as IL-17. Because Th17 cells are implicated in the pathology of autoimmune diseases (e.g., psoriasis, inflammatory bowel disease, multiple sclerosis), RORγT, whose activity is regulated by ligands, has been recognized as a drug target in potential therapies against these diseases. The identification of such ligands is time-consuming and usually requires the screening of chemical libraries. Herein, using a Tanimoto similarity search, we found corosolic acid and other pentacyclic tritepenes in the library we previously screened as compounds highly similar to the RORγT inverse agonist ursolic acid. Furthermore, using gene reporter assays and Th17 lymphocytes, we distinguished compounds that exert stronger biological effects (ursolic, corosolic, and oleanolic acid) from those that are ineffective (asiatic and maslinic acids), providing evidence that such combinatorial methodology (in silico and experimental) might help wet screenings to achieve more accurate results, eliminating false negatives.

Indexed as

CD4-Positive T-LymphocytesCell DifferentiationCells, CulturedCell SurvivalComputer SimulationDrug Evaluation, PreclinicalDrug Inverse AgonismHumansInterleukin-17Molecular Docking SimulationMolecular StructureNuclear Receptor Subfamily 1, Group F, Member 3Oleanolic AcidPeptide MappingSmall Molecule LibrariesTh17 Cellscorosolic acidInterleukin-17Nuclear Receptor Subfamily 1, Group F, Member 3Oleanolic AcidRORC protein, humanSmall Molecule LibrariesTriterpenescalculated fingerprints of the molecular similaritycorosolic acidinverse agonistoleanolic acidRORCRORgammaTtanimoto similarityTh17

Identifiers

PMID35163824
PMCPMC8837092
OpenAlexW4211033539

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.